Duration of prophylaxis with trimethoprim-sulfamethoxazole in patients undergoing solid organ transplantation

被引：6
|
作者：
Malhotra, P. [1 ]
Rai, S. D. [1 ]
Hirschwerk, D. [1 ]
机构：
[1] Hofstra N Shore LIJ Sch Med, Div Infect Dis, Dept Med, Manhasset, NY 11030 USA
来源：
INFECTION | 2012年 / 40卷 / 04期
关键词：
PNEUMOCYSTIS-JIROVECI PNEUMONIA; RENAL-TRANSPLANTATION; RISK-FACTORS; RECIPIENTS; INFECTION; GLOBULIN; PREVENTION; REJECTION; INDUCTION; CARINII;
D O I：
10.1007/s15010-012-0277-y
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：473 / 475
页数：3
相关论文
共 50 条
  • [1] Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation
    Gabardi, Steven
    Millen, Peter
    Hurwitz, Shelley
    Martin, Spencer
    Roberts, Keri
    Chandraker, Anil
    CLINICAL TRANSPLANTATION, 2012, 26 (03) : E184 - E190
  • [2] Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
    Prasad, G. V. Ramesh
    Beckley, Jill
    Mathur, Mohit
    Gunasekaran, Madhushankar
    Nash, Michelle M.
    Rapi, Lindita
    Huang, Michael
    Zaltzman, Jeffrey S.
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [3] Prophylaxis against Pneumocystis pneumonia in pediatric and adult patients undergoing solid organ or hematopoietic stem cells transplantation
    Gambra, M. Pilar
    Bidart, Teresa
    REVISTA CHILENA DE INFECTOLOGIA, 2012, 29 : 19 - 22
  • [4] Has the Time Come for Routine Trimethoprim-Sulfamethoxazole Prophylaxis in Patients Taking Biologic Therapies?
    Bodro, Marta
    Paterson, David L.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (11) : 1621 - 1628
  • [5] Response: Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients
    Siscos, Spyros M.
    Neill, Brett C.
    Tarantino, Isadore S.
    Aires, Daniel J.
    Rajpara, Anand
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E371 - E372
  • [6] Prophylaxis against tuberculosis in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation
    Lafourcade, Monica
    REVISTA CHILENA DE INFECTOLOGIA, 2012, 29 : 45 - 47
  • [7] Clinical Characteristics and Epidemiological Analysis of Pneumocystis Jirovecii Pneumonia Infection in Kidney Transplant Patients with Trimethoprim-Sulfamethoxazole Dose Reduction Prophylaxis Strategy
    Shan, Wenya
    Wang, Liangping
    Qin, Jiayi
    Peng, Wenhan
    Ma, Kuifen
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 2299 - 2306
  • [8] Failures of once-a-week trimethoprim-sulfamethoxazole prophylaxis in children undergoing allogeneic hematopoietic stem cell transplant
    Castagnola, Elio
    Mesini, Alessio
    Saffioti, Carolina
    Moscatelli, Andrea
    Pierri, Filomena
    Giardino, Stefano
    Faraci, Maura
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (01)
  • [9] A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients
    Lontos, Steve
    Shelton, Edward
    Angus, Peter W.
    Vaughan, Rhys
    Roberts, Stuart K.
    Gordon, Adam
    Gow, Paul J.
    JOURNAL OF DIGESTIVE DISEASES, 2014, 15 (05) : 260 - 267
  • [10] DESENSITIZATION TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HIV-INFECTED PATIENTS
    ABSAR, N
    DANESHVAR, H
    BEALL, G
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (06) : 1001 - 1005
12345